CClinicalTrials.gg
CompletedNCT01941667Updated Oct 3, 2017

Transitional Telehealth Home Care: REACH

An interventional study of Daily Messages, Virtual Home Visits and Usual Care in Congenital Heart Disease and Post Cardiac Surgery, sponsored by Children's Hospital of Philadelphia. Completed at 2 sites in United States. Open to participants aged 2 Weeks to 5 Months. Per ClinicalTrials.gov, last updated 2017-10-03.

Sponsored by Children's Hospital of Philadelphia · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
218
Allocation
Randomized
Ages
2 Weeks to 5 Months
Sex
All
01

Study summary

The investigators want to determine if additional, increased contact with infants and families discharged to home after cardiac surgery improves infant and parent outcomes as compared to usual care.

Read the detailed description

The investigators want to compare videoconferencing (SKYPE or FACTIME) and a monitoring system called Buddy Check is helpful. Buddy Check is a web-based tool using speech and internet technology to maintain contact with the health care team.

Infants are randomized to usual care or the intervention which uses automated daily phone calls and 2 virtual home visits each week. Weights, oxygen levels, and amount of food taken are obtained by the primary caregiver (parent) daily and sent via automated phone call, text message or email messages based on primary caregiver's desired.

02

Conditions studied

  • Congenital Heart Disease
  • Post Cardiac Surgery

Keywords

  • Congenital Heart Disease
  • Neonates and infants
  • Telehealth
  • Virtual Home Visits
03

In context

Heart Diseases

3,639 studies on the registry are indexed under Heart Diseases; 461 are open to participants now.

This study's enrollment of 218 is above the median of 100 across 1,778 interventional studies indexed under Heart Diseases.

Browse Heart Diseases studies →

Lead sponsor

Children's Hospital of Philadelphia is the lead sponsor of 480 studies on the registry; 85 are open to participants now.

Of its 28 completed or terminated interventional studies of FDA-regulated products, 22 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
2 Weeks to 5 Months
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Cardiac surgery within 2.5 weeks of life,
  • Diagnosis of congenital heart disease,
  • Post menstrual age 37 weeks and older;
  • Minimum birth weight 2500 grams,
  • At least one parent speaks and reads English,
  • Anticipated discharge by 21 days of life

Exclusion criteria

Exclusion Criteria:

  • Cardiomyopathy,
  • Diagnosis of Genetic syndrome
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
218 participants (actual)

Study arms

  • Experimental
    Daily Messages, virtual home visits

    Intervention includes: Measuring daily weights, 24 hour intake, heart rate, oxygen level Daily messages requesting weight, intake, pulse ox and pulse are automated Virtual home visits occur twice weekly where the investigators see the infant and families.

    Behavioral: Daily Messages, Virtual Home Visits

  • Placebo comparator
    Usual Care

    Infants will have usual care as defined by cardiology.

    Other: Usual Care

Interventions

  • BehavioralDaily Messages, Virtual Home Visits

    Intervention includes: Measuring daily weights, 24 hour intake, heart rate, oxygen level Daily messages requesting weight, intake, pulse ox and pulse are automated Virtual home visits occur twice weekly where the investigators see the infant and families.

  • OtherUsual Care

    Usual care as defined by by the Cardiology Department.

06

What researchers measure

Primary outcomes

  1. Parental Stress Score

    Parental Stress will be measured through the use of the total score of Parental Stress Index collected at the completion of the study period for the infant and family, approximately 5 months of infant's life.

    Time frame: Within 5 months of infant's life

Secondary outcomes

  1. Parental Quality of life Score

    Parental Quality of life will be measured by total score of "QOL, The Ulm Quality of Life Inventory for Parents (ULQIE)" collected at the completion of the study period for the infant and family, approximately 5 months of infant's life.

    Time frame: Within 5 months of infant's life

  2. Parental Social Isolation Score

    Parental social isolation will be measured by the total score on the Enriched SocialSupport Index with higher scores indicating more support which is collected within 5 months of the infant's life.

    Time frame: Within 5 months of Infant's life.

  3. Weight Gain at 5 months.

    Weight gain will be measured by change in z scores of infant's weight (measured in grams)which will be obtained at discharge from the hospital and at the end of the study period, approximately 5 months of life.

    Time frame: Within 5 months of life

  4. Post Traumatic Stress Disorder Symptoms

    Post Traumatic Stress Disorder Symptoms will be measured by the number of symptoms on the Post Traumatic Stress Disorder Scale at the end of the study period, within 5 months of the infant's life.

    Time frame: Within 5 month's of Infant's Life

Other outcomes

  1. Health Care Resource Utilization

    Health Care Utilization will be measured by per patient costs based on number of re-hospitalizations, Length of Stay of re-hospitalization, number of emergency department visits and number of acute care visits within 5 months of infant's life.

    Time frame: Within 5 month's of infants life.

07

Study locations

2 sites
  • Cincinnati Children's Hospital Medical Center
    Cincinnati, Ohio 45229, United States
  • Children's Hospital of PHiladelphia
    Philadelphia, Pennsylvania 19104, United States
08

References and documents

Publications

  • Golfenshtein N, Lisanti AJ, Cui N, Cooper BM. Predictors of Post-traumatic stress symptomology in parents of infants with Congenital Heart Disease post-surgery and after four months. J Pediatr Nurs. 2022 Jan-Feb;62:17-22. doi: 10.1016/j.pedn.2021.11.013. Epub 2021 Nov 25. PubMed 34839196 ↗
  • Medoff Cooper B, Marino BS, Fleck DA, Lisanti AJ, Golfenshtein N, Ravishankar C, Costello JM, Huang L, Hanlon AL, Curley MAQ. Telehealth Home Monitoring and Postcardiac Surgery for Congenital Heart Disease. Pediatrics. 2020 Sep;146(3):e20200531. doi: 10.1542/peds.2020-0531. PubMed 32817266 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 3, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01941667
Lead sponsor
Children's Hospital of Philadelphia
Collaborators
Children's Hospital Medical Center, Cincinnati, National Institutes of Health (NIH)
Responsible party
Sponsor
First posted
Sep 13, 2013
Start date
Jul 2012
Primary completion
Nov 2016
Completion
Jul 2017
Last update
Oct 3, 2017

Study contacts

Barbara Medoff-Cooper, PhD
principal investigator · Children's Hospital of Philadelphia

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion